AXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering Patients
November 01, 2016 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Nov. 01, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has begun...
Neil Gibbons Joins Valmiki 504 to Run a New Orleans Based Food + Food Tech Incubator
August 24, 2016 04:00 ET
|
Valmiki Capital Management LP
NEW ORLEANS, LA and NEW YORK, NY--(Marketwired - August 24, 2016) - Today Valmiki 504 LLC, a New Orleans-based venture capital firm, announced that Neil Gibbons will join the firm as Venture Partner...
Vinotemp Launches Brushed Stainless Modular Under Stairs Wine Cabinet at the International Builders' Show (IBS) 2015
January 20, 2015 03:08 ET
|
Vinotemp International
LOS ANGELES, Jan. 20, 2015 (GLOBE NEWSWIRE) -- Vinotemp
®, a recognized leader in the wine
storage and refrigeration industry for 30 years, is unveiling the
Brushed Stainless Modular...
Photo Release -- Top Global Experts Join AXIM Biotechnologies Advisory Board
November 06, 2014 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Nov. 6, 2014 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM) is setting the "green standard" in the industrial hemp industry, tapping two world-renown experts to advise on the Company's...
Healthy Choices at Every Meal
June 20, 2013 05:00 ET
|
VSL#3
MISSION, KS--(Marketwired - Jun 20, 2013) - (Family Features) For families of the nearly 30 percent of the general population who suffer from irritable bowel syndrome, making healthy diet decisions...
Novogen's Investigational Drug for Inflammatory Bowel Disease Has Positive Results Following Phase Ib Trial
December 04, 2007 08:01 ET
|
Novogen, Limited
STAMFORD, CT and SYDNEY, AUSTRALIA--(Marketwire - December 4, 2007) - A recently completed
Phase Ib clinical trial of a new drug to treat inflammatory bowel disease
(IBD) indicates that treatment may...